04/07/2025
We are proud to share that Espansione Group’s cutting-edge Light-Based Therapeutic Platform has been officially recognized in the TFOS DEWS III Report—a globally respected reference for dry eye disease research and treatment guidelines.✨
Published in the American Journal of Ophthalmology, the TFOS DEWS III Report acknowledges Photobiomodulation Low-level Light Therapy (LLLT) — delivered through our eye-light®️ device — as an effective, evidence-backed approach for managing tear film instability, meibomian gland dysfunction, and inflammatory conditions of the ocular surface.
As the official distributor of Espansione in Indonesia, we are committed to bringing the latest, evidence-backed technology to eye care professionals and helping them deliver safe, non-invasive, and effective treatments to patients.
Want to know more? Access the full lenght publication on American Journal of Ophthalmology.🔎
-IPL -LLLT